Atlas Trials

EpiDestiny, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch EpiDestiny, Inc.

RecordFirmDate
To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males (NCT05816356)EpiDestiny, Inc.2023-03-24
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease (NCT04055818)EpiDestiny, Inc.2020-01-24
Effect of Food on the Pharmacokinetics of Decitabine/Tetrahydrouridine Combination Capsules in Healthy Adult Subjects (NCT04086238)EpiDestiny, Inc.2019-10-08
Randomized, Single-dose, Crossover Study of 4 Decitabine and Tetrahydrouridine (EPI01) Formulations in Healthy Subjects (NCT03828084)EpiDestiny, Inc.2019-04-03

Track EpiDestiny, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.